MGX’s gene editing uses metagenomics and AI to build a “toolbox” of nucleases and base editors. Currently, their main application seems to be heading toward Hemophilia A, but even this IP is in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback